Navigation Links
Global High Throughput Screening (HTS) Industry
Date:9/8/2011

NEW YORK, Sept. 8, 2011 /PRNewswire/ --Reportlinker.com announces that a new market research report is available in its catalogue:

Global High Throughput Screening (HTS) Industry

http://www.reportlinker.com/p0611062/Global-High-Throughput-Screening-HTS-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Disc

This report analyzes the worldwide markets for High Throughput Screening (HTS) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. A six-year historic analysis is also provided for these markets. The report profiles 103 companies including many key and niche players such as Agilent Technologies Inc., BIOCIUS Life Sciences, Inc, Aurora Biomed Inc., Axxam SpA, Beckman Coulter, Inc., BioFocus DPI Ltd., Bio-Rad Laboratories, Inc., BMG LABTECH GmbH, Caliper Life Sciences, Inc., Corning Inc., DiscoveRx Corporation, EVOTEC BioSystems, ForteBio, Inc., Genedata AG, IntelliCyt Corporation, Life Technologies Corporation, Luminex Corporation, Molecular Devices Inc., PerkinElmer Inc., Roche Applied Sciences, Sigma-Aldrich Corporation, and Tecan Group Ltd. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1

Study Reliability and Reporting Limitations 1

Disclaimers 2

Data Interpretation & Reporting Level 3

Quantitative Techniques & Analytics 3

Product Definitions and Scope of Study 3

2. INDUSTRY OVERVIEW 4

A Prelude 4

Current and Future Analysis 4

Market Scenario 4

How Far Has HTS Been Successful - A Case For and Against HTS 6

Market Share Findings 7

Table 1: World Liquid Handling Market (2010): Percentage

Market Share Breakdown of Leading Players (includes

corresponding Graph/Chart) 7

Table 2: World Robotics Market (2010): Percentage Market

Share Breakdown of Leading Players (includes corresponding

Graph/Chart) 8

Table 3: World Microplate Readers Market (2010): Percentage

Market Share Breakdown of Leading Players (includes

corresponding Graph/Chart) 8

3. MARKET TRENDS & ISSUES 9

HTS Adapts to Varied Lead Discovery Needs 9

Compound Library and Target Selection Equally Important as

Screening 9

Cell-based Assays Represent the Primary Drug Discovery Tool in

HTS Labs 9

Smaller Companies and Academia Can Now Afford HTS 9

Innovation in Screening Guarantees Success for Drug Discovery

Programs 10

HTS Advancements Promise a Bright Future for Stem Cell Research 10

HTS in the Discovery of Drug for Alzheimer's Disease 11

Need for Stringent QA System to Keep Failures at Bay 11

HTS Used in Identification of Kinase Inhibitors 12

4. HTS TECHNOLOGY OVERVIEW 13

What Drives HTS Labs Towards New Technologies 13

Major HTS Technologies 13

Miniaturization 13

HTS Miniaturization - Technology Developments 14

IVC - A Miniaturized, Powerful HTS Technology 14

Target Selection 14

Label-free Technologies 15

High-Content Screening (HCS) 15

Innovations in Cell Culture 15

Compound Libraries Expansion 16

HTS - A Historical Perspective 16

5. PRODUCT OVERVIEW 18

High Throughput Research (HTR) 18

High Throughput - An Advanced Materials Research Approach 18

Pharmaceutical Industry Leads the Way 18

High Throughput Improves R&D Efficiency 19

High Throughput Screening (HTS) 19

The Equipment 19

The Process 20

HTS Robotics Supports Miniaturization 21

HTS and uHTS 21

Functional and Non-Functional - Two Types of High Throughput

Assays 21

Setting up HTS Facilities - An Expensive Affair 21

Important Components of HTS 22

Few popular Chemical Libraries Used in Chemical Biology and

Drug Discovery 22

Table 4: Screening Throughput of Plates (includes

corresponding Graph/Chart) 22

Distinctions Between Bench Top and HTS Assays 23

6. HTS AND THE PHARMA INDUSTRY 24

Impact of HTS on the Pharmaceutical Industry 24

The Underlying Technology and Market Factors 24

High Costs Involved with Sophistication - A Matter of Concern 24

The HTS Business in Pharma Industry 25

What Lies Ahead for HTS 25

Hit and Lead Generation Strategies 26

Different Stages in Hit and Lead Generation 26

From 'Hit' to 'Lead' in HTS - A Complex Endeavor 26

7. DRUG DISCOVERY - AN OVERVIEW 28

Drug Discovery - Definition 28

Drug Discovery Process 28

Drug Discovery Technologies 28

8. COMPUTER AIDED DRUG DISCOVERY (CADD) 30

The Evolution of Computer Aided Drug Discovery (CADD) Processes 30

CADD 30

High Throughput Screening 30

Virtual Screening 31

Cloud Computing 31

9. PRODUCT INNOVATIONS/INTRODUCTIONS 32

Tox21 Launches Novel Robotic High Speed Screening System 32

Life Technologies Introduces TaqMan OpenArray MicroRNA Panels 32

Zyleris Introduces Screening Service for Drug Development 32

Genosphere Introduces PepLib™ Custom Peptide Library Synthesis 33

PerkinElmer Launches Lance Ultra cAMP Detection Kit for

Profiling GPCRs 33

PerkinElmer Introduces Epigenetics Detection Reagents for HTS

of New Drug Candidates 33

Agilent and BIOCIUS Introduce RF360 High Resolution System 33

High Throughput Genomics and Luminex Introduce qBead Assay 34

IntelliCyt Launches HTFCTM Screening System 34

Luminex Corporation Launches FLEXMAP 3D, a High-Throughput System 34

ForteBio Introduces Advanced Instruments for Life Science

Research Industry 35

BioTrove Introduces RapidFire® 300 System for HTS of ADME Assays 35

Sigma-Aldrich Launches PrecisioTM Kinases for High Througput

Profiling 36

Genedata Launches Genedata Screener 7.0 for HCS and HTS Analysis 36

Roche Diagnostics Introduces RTCA HT Instrument 36

Axxam and CyBio Introduce An Advanced Screening Station 37

BMG LABTECH Unveils PHERAstar FS Reader for HTS Applications 37

PharmaDiagnostics Unveils SoPRano CA1 Assay Kit 37

SwitchGear Genomics Introduces High Throughput Screening Tools 38

PerkinElmer Launches Upgraded MicroBeta®2 Microplate Counter

Platform 38

Intellicyt Launches Hypercyt Based Application, Flowtox Screening 38

10. RECENT INDUSTRY ACTIVITY 39

Agilent Technologies Takes Over BIOCIUS Life Sciences 39

EVOTEC BioSystems Takes Over Kinaxo Biotech 39

Beckman Coulter and Vitrology Ink Biologics Testing

Partnership Agreement 39

Sigma Life Sciences and King's College Co-develop Target

Identification Technology 40

Lundbeck and Compound Focus Ink Compound Management Agreement 40

Ligand to Divest Combinatorial Library and Certain

Technologies to Venenum 40

DiscoveRx Corp Acquires Kinase Screening Service Division of

Ambit Biosciences 40

Omeros Takes Over GPCR Assay Technology from Patabios 41

TGS Collaborates with CarnaBio for Providing Drug Discovery

Services 41

AstraZeneca and MRC Technology Team Up for Drug Discovery,

Share Compound Libraries 41

Evotec and Biotech Partner for Small Molecule Modulator

Identification 42

ForteBio and Tecan Team Up to Provide Automated Label-Free Assays 42

Protein Attachment and Blue Sky Biotech Ink Licensing Agreement 42

BioAtla and Halozyme Team Up 42

Jubilant Biosys and DiscoveRx Enter into an Co-marketing

Agreement 43

Plasticell Inks Partnership Agreement with Sigma-Aldrich 43

Redpoint Bio Receives US Patent for its HTS Assay for TRPm5

Ion Channel 43

Corning Takes Over Axygen BioScience 44

ChanTest Takes over Applied Cell Sciences 44

Nexus Biosystems Takes over Aurora Biotechnologies 44

PerkinElmer Acquires Assets of GE Healthcare 45

Cellectis and Laboratoires Servier Ink Licensing Agreement 45

BioFocus to Integrate TET Technology in HTS Services 45

BioFocus DPI Upgrades High-Throughput Screening Library 45

Ono Pharmaceutical and Evotec Extend Research Collaboration 45

Randox Labs and Seegene Enter into Agreement 46

BioFocus DPI and Cellectricon Enter into Collaboration 46

Evotec and DiscoveRx Ink Agreement to Support HTS Services 46

Corning Announces a Major Milestone in Label- Free High

Throughput Screening 47

11. FOCUS ON SELECT GLOBAL PLAYERS 48

Agilent Technologies Inc. (US) 48

BIOCIUS Life Sciences, Inc. (US) 48

Aurora Biomed Inc. (Canada) 49

Axxam SpA (Italy) 49

Beckman Coulter, Inc (US) 49

BioFocus DPI Ltd (UK) 50

Bio-Rad Laboratories, Inc. (US) 50

BMG LABTECH GmbH (Germany) 51

Caliper Life Sciences, Inc (US) 51

Corning Inc (US) 52

DiscoveRx Corporation (US) 52

EVOTEC BioSystems (Germany) 53

ForteBio, Inc (US) 53

Genedata AG (Switzerland) 53

IntelliCyt Corporation (US) 53

Life Technologies Corporation (US) 54

Luminex Corporation (US) 54

Molecular Devices Inc. (US) 54

PerkinElmer Inc (US) 55

Roche Applied Sciences (Germany) 56

Sigma-Aldrich Corporation (US) 56

Tecan Group Ltd. (Switzerland) 56

12. GLOBAL MARKET PERSPECTIVE 58

Table 5: World Recent Past, Current & Future Analysis for High

Throughput Screening by Geographic Region - US, Canada, Japan,

Europe and Rest of World Markets Independently Analyzed with

Annual Revenues in US$ Million for Years 2009 through 2017

(includes corresponding Graph/Chart) 58

Table 6: World Historic Review for High Throughput Screening

by Geographic Region - US, Canada, Japan, Europe and Rest of

World Markets Independently Analyzed with Annual Revenues in

US$ Million for Years 2003 through 2008 (includes

corresponding Graph/Chart) 59

Table 7: World 15-Year Perspective for High Throughput

Screening by Geographic Region - Percentage Breakdown of

Dollar Revenues for US, Japan, Europe, and Rest of World

Markets for Years 2003, 2010 & 2017 (includes corresponding

Graph/Chart) 60

13. THE UNITED STATES 61

A.Market Analysis 61

Outlook 61

Factors Driving Growth in the US HTS Market 61

Government Providing a Helping Hand 61

Product Introductions 62

Recent Industry Activity 65

Key Players 68

B.Market Analytics 76

Table 8: US Recent Past, Current & Future Analysis for High

Throughput Screening Market Independently Analyzed with

Annual Revenues in US$ Million for Years 2009 through 2017

(includes corresponding Graph/Chart) 76

Table 9: US Historic Review for High Throughput Screening

Market Independently Analyzed with Annual Revenues in US$

Million for Years 2003 through 2008 (includes corresponding

Graph/Chart) 76

14. CANADA 77

A.Market Analysis 77

Outlook 77

Key Players 77

B.Market Analytics 78

Table 10: Canadian Recent Past, Current & Future Analysis

for High Throughput Screening Market Independently Analyzed

with Annual Revenues in US$ Million for Years 2009 through

2017 (includes corresponding Graph/Chart) 78

Table 11: Canadian Historic Review for High Throughput

Screening Market Independently Analyzed with Annual Revenues

in US$ Million for Years 2003 through 2008 (includes

corresponding Graph/Chart) 78

15. JAPAN 79

A.Market Analysis 79

Outlook 79

Recent Industry Activity 79

B.Market Analytics 80

Table 12: Japanese Recent Past, Current & Future Analysis

for High Throughput Screening Market Independently Analyzed

with Annual Revenues in US$ Million for Years 2009 through

2017 (includes corresponding Graph/Chart) 80

Table 13: Japanese Historic Review for High Throughput

Screening Market Independently Analyzed with Annual Revenues

in US$ Million for Years 2003 through 2008 (includes

corresponding Graph/Chart) 80

16. EUROPE 81

A.Market Analysis 81

Outlook 81

Market Shifts Towards Maturity - Technological Innovations

Come to the Rescue 81

Product Introductions 81

Recent Industry Activity 83

Key Players 85

B.Market Analytics 88

Table 14: European Recent Past, Current & Future Analysis

for High Throughput Screening Market Independently Analyzed

with Annual Revenues in US$ Million for Years 2009 through

2017 (includes corresponding Graph/Chart) 88

Table 15: European Historic Review for High Throughput

Screening Market Independently Analyzed with Annual Revenues

in US$ Million for Years 2003 through 2008 (includes

corresponding Graph/Chart) 89

17. REST OF WORLD 90

A.Market Analysis 90

Outlook 90

Regional Overview 90

HTS Gaining Ground in APAC 90

China 90

China Emerges as the Major Outsourcer for Drug Discovery 90

Few Problem Areas Exist 91

What Outsourcers Need to Look Forward to 91

Life Sciences Market in China Continues to Thrive Despite

Recession 91

B.Market Analytics 92

Table 16: Rest of World Recent Past, Current & Future

Analysis for High Throughput Screening Market Independently

Analyzed with Annual Revenues in US$ Million for Years 2009

through 2017 (includes corresponding Graph/Chart) 92

Table 17: Rest of World Historic Review for High Throughput

Screening Market Independently Analyzed with Annual Revenues

in US$ Million for Years 2003 through 2008 (includes

corresponding Graph/Chart) 92

COMPETITIVE LANDSCAPE

Total Companies Profiled: 103 (including Divisions/Subsidiaries - 106)

------------------------------------------

Region/Country Players

------------------------------------------

The United States 64

Canada 1

Japan 2

Europe 35

France 4

Germany 10

The United Kingdom 12

Italy 1

Rest of Europe 8

Asia-Pacific (Excluding Japan) 4

------------------------------------------

To order this report:

Drug Discovery and Development Industry: Global High Throughput Screening (HTS) Industry

Drug Discovery and Development Business News

More  Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Global Metabolomics Industry
2. Global Molecular Cytogenetics Industry
3. BioStorage Technologies, Inc. to Hold Global Sample Management Benchmarking Symposium in Conjunction With 2011 IIR Biorepositories Conference
4. ChromaDex to Present at the Rodman & Renshaw Annual Global Investment Conference
5. Hadasit to Present at the Rodman & Renshaw Annual Global Investment Conference on September 13, 2011
6. Life Technologies to Present at the UBS 2011 Global Life Sciences Conference
7. Jeunesse Global Announces New Medical Advisory Board Member and Admittance Into the Direct Selling Association (DSA).
8. IndiaMART.com to Step Up B2B Matchmaking at Global Trade Events
9. FMC Corporation Announces Exclusive Global Development and Supply Agreements for Chr. Hansen Biological Products
10. Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015)
11. Global Genetic Testing Market Analysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... 9, 2016 This market research report on ... future prospects of the market in terms of revenue ... engaged in the manufacture of microbiology culture media and ... a market snapshot providing the overall information of various ... This section also provides the overall information and data ...
(Date:2/9/2016)... Three-Year Initiative Supports Next Generation of Medical Geneticists and  ... Experiences SHPG ) ... of children born with rare diseases, as well as the future ... a new initiative designed to positively affect the lives of children ... disease care. --> To mark the company,s founding 30 ...
(Date:2/9/2016)... , Feb. 9, 2016 ... Inhibitors-Pipeline Insights, 2016", report provides in depth ... development activities around the Protein-Tyrosine Phosphatase 1B ... product profiles in various stages of development ... II, Phase III and Preregistration. Report covers ...
(Date:2/8/2016)... PLYMOUTH MEETING, Pa. , Feb. 8, 2016 /PRNewswire-USNewswire/ ... place of standard bone cement products to prevent infection ... a question that the experts at ECRI Institute have ... Cement: Fighting Infection or Fighting Your Bottom Line?" ... or Fighting Your Bottom Line?" --> ...
Breaking Biology Technology:
(Date:2/9/2016)... Feb. 9, 2016 Vigilant Solutions announces today that ... (LPR) to develop a lead in a difficult homicide case. ... data to locate the suspect vehicle. Due to the ongoing ... have been omitted at the agency,s request. ... explains, "Our victim was found deceased at an intersection here ...
(Date:2/3/2016)... GOTHENBURG, Sweden , February 4, 2016 ... Revenues amounted to SEK 1,351.5 M (105.0), up 1,187% compared with fourth ... Operating profit amounted to SEK 517.6 M (loss: 30.0). Earnings ... from operating activities was SEK 537.4 M (neg: 74.7). , ... , Revenues amounted to SEK 2,900.5 M (233.6), up 1,142% ...
(Date:2/2/2016)... , Feb. 2, 2016  BioMEMS ... are primarily focused on medical screening and ... point-of-care parameters. Wearable devices that facilitate and ... freedom of movement are being bolstered through ... human biomedical signal acquisition coupled with wireless ...
Breaking Biology News(10 mins):